Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluating Potential Clinical Utilities of Circulating Tumor DNA in Gastric Cancer

NCT04000425 is registered in ClinicalTrials.gov with Shanghai Zhongshan Hospital as lead sponsor.

NCT NCT04000425
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04000425 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluating Potential Clinical Utilities of Circulating Tumor DNA in Gastric Cancer
Lead sponsor
Shanghai Zhongshan Hospital
Phase
Observational
Overall status
Unknown status
Start date
December 1, 2018
Completion date
May 31, 2021
Enrollment
55 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

gastric cancer